SETDB1 transcriptionally represses TEs as an effector in the KAP1-built repressive complex (Matsui et al., 2010); therefore, it stands to reason to give the first consideration to these TEs for their expression change in the SH tumor samples. This evidence concerns the gene SETDB1 and neoplasm.